三聚氰胺与1,3-苯二磺酸盐共晶中的氢键作用

合成了一个新的配合物[(HMA )2.(BD2-)].H2O(HMA=三聚氰胺,BD2-=1,3-苯二磺酸盐),通过X射线衍射、元素分析、红外光谱、热重分析对其进行了结构表征,该晶体属于三斜晶系,空间群P1,晶胞参数:a=9.305(1),b=10.272(1),c=12.297(1),α=80.56(2)°,β=71.47(2)°,γ=63.27(2)°,V=994.9(2)3,μ=0.337mm-1,Dc=1.697g/cm3,F(000)=528,R=0.0649,wR2=0.1467,2990个可观察衍射点。三聚氰胺被质子化,相邻的三聚氰胺分子通过N—H…N氢键形成(MAH )∞带子,而相邻的BD2-阴离子通过C—H…O弱氢键形成一条波状的带子(BD2-)∞,N—H…O、N—H…Ow氢键将相邻的(MAH )x(阳离子带子和(BD2-)∞阴离子带子连接成二维网络,层状结构通过N—H…O氢键以及π…π作用堆积成三维微孔结构。     

新型镍配合物的溶剂热合成及其晶体结构

以2-乙氧基-6-亚氨甲基苯酚(HL)为配体,与氨水和Ni(ClO4)2.6H2O经溶剂热法合成了新型镍配合物[Ni(L)2](1),其结构经IR,元素分析和XRD表征。1属三斜晶系,Pī空间群,晶胞参数a=0.843 3(3)nm,b=1.009 4(2)nm,c=1.188 4(2)nm,α=111.16(3)°,β=97.43(3)°,γ=102.43(3)°,V=0.897 2(11)nm3,Mr=387.05,Z=2,Dc=1 433 g.cm-3,F(000)=404,μ=1.105 mm-1,S=1.015。1中Ni2-分别与两个L-上的两个N原子和两个O原子配位,形成了平面四边形几何构型。分子通过一对N-H┈O氢键形成二聚体;二聚体进一步通过N-H┈O氢键和C-H┈Ni氢键的相互作用形成二维网状结构。     

cis-2,12-二取代环十二酮的合成及晶体结构

以环十二酮为原料合成了cis-2-苯磺酰基-12-苄基环十二酮、2-苯磺酰基-12-溴代环十二酮和2,12-二苄基环十二酮,它们的结构通过1H NMR,13C NMR和元素分析表征.化合物4的晶体结构参数:C25H32O3S,Mr=412.57,三斜晶系,空间群P1,a=0.96531(4)nm,b=1.12703(5)nm,c=1.17486(5)nm,α=89.278(2)°,β=75.582(2)°,γ=65.385(2)°,V=1.11938(8)nm3,Dc=1.224 g/cm3,Z=2,F(000)=444,μ(Mo Kα)=0.167 mm-1,S=1.038.化合物6的晶体结构参数:C18H25BrO3S,Mr=401.35,三斜晶系,空间群P1,a=0.77771(16)nm,b=1.0143(2)nm,c=1.2040(2)nm,α=89.46(3)°,β=80.13(3)°,γ=75.27(3)°,V=0.9044(3)nm3,Dc=1.474 g/cm3,Z=2,F(000)=416和μ(Mo Kα)=2.400 mm-1,S=1.042.cis-2-苯磺酰基-12-苄基环十二酮和cis-2-苯磺酰基-12-溴代环十二酮的X射线衍射结果表明,环十二酮母体骨架采取[3333]-2-酮构象,较小的取代基位于角顺位,较大的取代基位于边外向位.     

基于萘基新型冠醚的合成、晶体结构及其对联吡啶盐的络合性能研究

以2,7-二羟基萘为起始原料,经与8-(对甲苯磺酰氧基)-3,6-二氧-1-辛醇醚化,再与对甲苯磺酰氯酯化得7,7最后与2,7-二羟基萘在碳酸铯为碱作用下得基于2,7-二羟基萘基块新型的冠醚,三步总收率为35%.利用单晶X衍射研究其结构,晶体为三斜晶系,P-1空间群,a=8.165(3),b=13.435(4),c=14.083(3),γ=64.11(2)°,β=80.40(3)°,γ=88.19(3)°,V=1368.9(7)3,Z=2,Dc=1.331 g/cm3,λ=0.071070 nm,μ(Mo Kα)=1.331 mm-1,Mr=353.22,F(000)=584.在1的晶体结构中,两个萘基块通过二缩三乙二醇醚键相连形成1个二萘并[30]-冠-8大环结构,空腔大小为8.2×12.0,分子呈Z型结构.通过核磁研究了主体分子1对联吡啶盐在溶液中的相互络合作用.     

1-苯甲酰基-3-(4,6-二甲氧基嘧啶-2-氨基)硫脲的合成、晶体结构及生物活性

以2-氨基-4,6-二甲氧基嘧啶、硫氰酸钾和苯甲酰氯为原料,在乙酸乙酯中合成了1-苯甲酰基-3-(4,6-二甲氧基嘧啶-2-氨基)硫脲,并用X射线单晶衍射法测定其晶体结构。结果表明,每个结构单元中有4个分子,该化合物属于三斜系,P1空间群,a=0.9040(2)nm,b=1.8285(4)nm,c=1.8931(5)nm,α=70.217(4)°,β=80.583(4)°,γ=84.110(4)°,V=2901.3(12)3,Dc=1.458g/cm3,μ=0.242mm-1,F(000)=1328,Z=8,R=0.0637,由2095个可观测衍射点[FO>4sig(FO)]得到的wR=0.1698。同层中相邻分子间的分子间氢键N—H…S(DA)和C—H…O(DA)的交叉作用以及层与层之间弱的π…π堆积作用使得化合物形成网状超分子结构。该结构的化合物具有良好的生物活性。     

锌配合物Zn(phen)(H2O)(3-mba)2的合成、结构表征及荧光性质

常温下,溶液法合成了一个单核结构的锌配合物Zn (phen)(H2O)(3-mba)2(phen:邻菲咯啉;3-Hmba∶3-甲基苯甲酸),并用红外光谱、元素分析、热重分析以及X射线单晶衍射表征了其结构.结果表明,配合物属于三斜晶系,空间群P1,晶胞参数:a=10.893(2)(A),b=11.461(2)(A),c=11.505(2)(A),α=95.54(3)°,β=115.80(3)°,γ =100.25(3)°,V=1247.9(4) (A)3,C28H24N2O5Zn,Mr=533.86,Z =2,Dc=1.421 g·cm-3,F(000) =552,最终偏离因子[I≥2σ(I)]R1=0.0471,wR2 =0.0954.在配位物分子中,中心锌离子是五配位模式,双分子间先通过O—H…O氢键形成二聚体,继而二聚体间通过相邻分子中的邻菲咯啉芳环的π-π堆积作用沿着a方向形成了一维超分子链.对配合物的荧光性能进行了测试.CCDC 1023439.     

配位聚合物[Ni(H_2O)_6]·[Ni_2(phen)_2(BTC)_2(H_2O)_4]·4H_2O的水热合成和结构表征

采用水热法合成了新的配合物[Ni(H2O)6].[Ni2(phen)2(BTC)2(H2O)4].4H2O(phen=邻菲啰啉;BTC=均苯三甲酸),采用X射线单晶衍射结构分析及元素分析、红外光谱等表征,并用TGA检测了该配合物的热稳定性.晶体属于三斜晶系,空间群为P-1,晶胞参数a=0.84038(7)nm,b=0.92048(8)nm,c=1.64793(14)nm,α=97.3850(10)°,β=102.7930(10)°,γ=104.9700(10)°,V=1.17736(17)nm3,F(000)=622,Z=1.标题化合物的不对称结构是由NiO6单元和1个二聚物Ni2N4O12单元组成的,该二聚物单元通过2个邻菲啰啉和2个均苯三甲酸分子构筑了1个八元环.氢键将2个独立的结构单元连接成三维结构.     

锌配合物Zn(phen)(H_2O)(3-mba)_2的合成、结构表征及荧光性质（英文）

常温下,溶液法合成了一个单核结构的锌配合物Zn(phen)(H2O)(3-mba)2(phen:邻菲咯啉;3-Hmba:3-甲基苯甲酸),并用红外光谱、元素分析、热重分析以及X射线单晶衍射表征了其结构。结果表明,配合物属于三斜晶系,空间群P 1,晶胞参数:a=10.893(2)A,b=11.461(2)A,c=11.505(2)A,α=95.54(3)°,β=115.80(3)°,γ=100.25(3)°,V=1247.9(4)A3,C28H24N2O5Zn,Mr=533.86,Z=2,Dc=1.421 g·cm-3,F(000)=552,最终偏离因子[I≥2σ(I)]R1=0.0471,wR2=0.0954。在配位物分子中,中心锌离子是五配位模式,双分子间先通过O—H…O氢键形成二聚体,继而二聚体间通过相邻分子中的邻菲咯啉芳环的π-π堆积作用沿着a方向形成了一维超分子链。对配合物的荧光性能进行了测试。CCDC 1023439。     

香豆素衍生物的合成及结构表征

合成了11个香豆素衍生物,产率53%—79%,利用元素分析、MS和¹HNMR对其结构进行了表征.同时,由2-氨基苯并噻唑(ABT)和8-甲氧基香豆素-3-甲酸乙酯(MCC)合成了给体-受体加合物ABT-MCC,通过X射线单晶衍射法测定了其晶体结构,晶体属三斜晶系,P1空间群,晶胞参数为:a=9.5978(19)Å,b=10.686(2)Å,c=10.693(2)Å,α=71.30(3)°,β=70.43(3)°,γ=88.99(3)°,V=973.9(3)ų,Z=2,D_x=1.359 mg/m³,μ=0.200 mm^-1,F(000)=416,R=0.0463,wR=0.0992.结果表明,在ABT-MCC晶体中,分子间通过N—H…N和N—H…O氢键作用形成对称的A…D…D′…A′氢键四聚体,并通过弱的C—H…O氢键连接成为一维超分子链状结构,进而分子间通过π-π堆积作用形成层状结构.     

两种色酮膦酸酯类化合物的合成及其结构表征

在超声波辐射下,以3-甲酰基色酮,对硝基苯胺和亚磷酸酯为原料,"一锅法"合成了两种含色酮环的α-氨基膦酸酯类化合物,通过IR,1H NMR,13C NMR,31P NMR,ESI-MS对其结构进行了测定和表征.对化合物4a进行了X射线衍射分析,O,O'-二乙基-α-对硝基苯氨基-α-(色酮-4-基)-甲基膦酸酯(4a)(CCDC:2080073)晶体属单斜晶系,C2/c空间群,晶胞参数为a=33.6146(11)(A),b=12.7607(4)(A),c=20.5344(4)(A),β=90.943(3)°,V=8806.9(4)(A)3,Z=16,C21H27N4O3P,Mr=432.36,Dc=1.304g· cm-3,μ=1.484,F(000)=3616,μ(CuKα)=1.54184 mm-1.     

4,4’-一氧二（苯胺灵）的合成和晶体结构

通过4,4’-一氧二（异氰酸苯酯）与异丙醇加成反应，合成标题化合物 4,4’-一氧二（苯胺灵）(Ⅰ) (C20H24N2O5, Mr=372.41)，并用X射线衍射、红外光谱、13C核磁共振、电子轰击质谱和元素分析对标题化合物进行表征. 晶体属于三斜晶系，空间群为P1晶体学参数为: a=0.85107(17), b=0.91164(18), c=1.45701(3) nm, α=80.44(3)°, β=85.25(3)°, γ=62.88(3)°, V=0.9922(3) nm3, Z=2, Dc=1.247 g•cm－3, μ(Mo Kα)=0.90 cm－1, F(000)=396.两个苯环平面之间的夹角为62.06° (0.06°). 晶体结构经全矩阵最小二乘法修正，最终偏离因子R=0.0520, wR=0.1434(对可观察点).此化合物应具有广谱的生物活性.     

Synthesis and Crystal Structure of 3-Benzyl-6-trichloromethyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

The title compound 3-benzyl-6-trichloromethyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole I （C11HTC13N4S, Mr = 333.62） has been synthesized, and its structure was determined by elemental analyses, IR, ^1H NMR, ^13C NMR, and X-ray diffractions. The crystal is of triclinic, space group P1^-, with a = 5.898（3）, b = 10.510（4）, c = 11.580（5） A, α = 74.936（7）, β= 75.476（7）, γ = 79.647（7）°, V= 665.9（5）/A^3, F（000） = 336, Z= 2, Dc = 1.664 g/cm^3, 2 = 0.71073A, p = 0.834 mm^-1, the final R = 0.0605 and wR = 0.0900. The secondary bonding interactions （SBIs） S…N and π-π stacking interactions are found in the crystal structure and they link the molecules into a three-dimensional network.     

Crystal Structure of 2-Amino-5,10-dioxo-4-aryl-5,10-dihydro-4H-naphtho [2,3-b]pyran-3-carboxylic Acid Ethyl Ester

The title compounds have been synthesized via a three-component reaction and their structures were characterized by IR, ^1H NMR, ^13C NMR and X-ray single-crystal diffraction. The crystal of compound 4a belongs to monoclinic, space group P121/c1 with a = 8.575（3）, b = 9.590（3）, c = 21.431（6）A, β = 91.172（3）°, V = 1762.1（9）A^3, Mr = 393.36, Z = 4, Dc= 1.483 g/cm^3, μ（MoKα） = 0.113 mm^-1, F（000） = 816, the final R = 0.0366 and wR = 0.0941. The crystal of compound 4b is of triclinic, space group P-1 with a = 8.6420（17）, b = 9.761（2）, c = 11.132（2） A, α = 97.51（3）, β = 97.86（3）, γ = 92.85（3）°, V = 920.1（3） A^3, Mr = 393.36, Z = 2, Dc = 1.420 g/cm^3, μ（MoKα） = 0.108 mm^-1, F（000） = 408, the final R = 0.0612 and wR = 0.1781. In each molecular structure, the naphthalene rings and pyran rings are almost coplanar with the latter in an envelope conformation. The rings formed by the N-H…O intramolecular hydrogen bonds are almost planar in these compounds. Their crystal packing is stabilized by intermolecular hydrogen bonds together with C-H…π and π-π stacking interactions.     

Synthesis and Crystal Structure of 3,3''-(2,2''-(Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(2-(4-chlorophenylamino)quinazolin-4(3H)-one)

The title compound 3,3'-(2,2'-(ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(2- (4-chlorophenylamino)quinazolin-4(3H)-one) 3 (C34H30Cl2N6O4, Mr = 657.54) has been synthesized and its crystal structure was determined by single-crystal X-ray diffraction analysis. It crystallizes in space group P1 with a = 9.9185(8), b = 10.6124(9), c = 15.4064(13) , α = 92.896(2), β = 103.813(2), γ = 94.635(2)°, V = 1565.5(2) 3, Z = 2, Dc = 1.395 g/cm3, μ = 0.257 mm–1, F(000) = 684, the final R = 0.0580 and wR = 0.1284 f...     

Synthesis and Crystal Structure of the Optical Activity of （Z）-Nitromethylene Neonicotinoid Analogue

A novel (Z)-nitromethylene neonicotinoid analogue (C23H27Cl2N5O4·2H2O) (II) with optical activity has been synthesized, the structure was characterized by elemental analysis, IR and 1H NMR spectra, and the (Z)-configuration was confirmed by single-crystal X-ray diffraction. The crystal belongs to triclinic, space group P1 with a = 7.4638(3), b = 12.6232(5), c = 15.2990(6), α = 71.907(1), β = 89.397(2), γ = 80.314(1)°, V = 1349.28(9)3, Z = 2, Dc = 1.340 g/cm3, μ = 0.286 mm-1, Mr = 544.43, F(000) = 572, S = 1.056, R = 0.0801 and wR = 0.2366 for 4998 unique reflections with 3012 observed ones (I > 2σ(I)). In the crystal, the dihedral angle between the pyridine and 4-Cl-phenyl rings is 58.13°. Intermolecular O–H···O, C–H···O and C–H···Cl hydrogen bonds involving water molecules stabilize the crystal structure.     

Synthesis and Crystal Structure of a Cu2+ Supra-molecular Complex [Na2Cu(BTA)2(H2O)8]·H2Owith a Three-dimensional Network Structure

A three-dimensional Cu2+ supramolecular complex [Na2Cu(BTA)2(H2O)8]·H2O 1 (H2BTA = bistetrazolylamine) was synthesized by reacting the aqueous solution of CuSO4·5H2O and H2BTA under stirring. The crystal structure of 1 was determined by single-crystal X-ray diffraction. The result indicates that 1 crystallizes in triclinic,space group P1,with a = 7.0518(2),b = 12.2692(2),c = 13.8583(3) ,α = 115.7260(10),β = 93.2440(10),γ = 98.3610(10)o,Mr = 573.90,V = 1059.01(4) 3,Z = 2,Dc = 1.800 g·cm-3,μ(MoKα) = 1.155 mm-1,F(000) = 586.0,S = 1.074,the final R = 0.0273 and wR = 0.0744 for 4334 observed reflections with Ⅰ > 2σ(Ⅰ). The Cu2+ ion is five-coordinated with a N4O1 donor set with τ = 0.153 according to the method of Addison et al. And the Na+ ions form an infinite main chain through bridging O atoms from coordinated water molecules. In 1,a three-dimensional supramolecular network is formed by O-H···O,O-H···N,N-H···O and N-H···N hydrogen bonds.     

Synthesis and Crystal Structure of 3-(Pyrrole-2''-carboxamido)propanoic Acid·(1/2)H2O

3-(Pyrrole-2'-carboxamido)propanoic acid I has been synthesized from the reaction of β-alanine methyl ester with 2-trichloroacetylpyrrole followed by saponifying and acidating in 85.4% yield, and the crystal structure of 3-(pyrrole-2'-carboxamido)propanoic acid· (1/2)H2O (C8H11N2O3.5, Mr = 191.19) was obtained and determined by X-ray diffraction method. The crystal is of monoclinic, space group C2/c with a = 19.010(4), b = 8.3515(17), c = 13.788(3) (A), β = 125.88(3)°, V = 1773.6(6) (A)3, Z = 8, Dc = 1.432 g/cm3, λ = 0.71073 (A), μ-MoKα) = 0.114 mm-1 and F(000) = 768. The structure was refined to R = 0.0354 and wR = 0.0942 for 1642 observed reflections with I > 2σ(I). It is revealed that the title compound has one pyrrole ring and one propionic acid subchain linked by an amido bond at C(4), and there are 8 molecules of com- pound I and 4 crystal water molecules in each unit cell. The supramolecular layers are stabilized by the hydrogen bonds of N(2) H…O(2), N(1) H…O(4), O(4) H(1W)…O(2) and O(3) H…O(1).     

二维配合物{[Cd(bpds)(bpp)_2]·2H_2O}_n的水热合成、晶体结构和荧光性质研究(英文)

A novel two-dimensional cadmium(Ⅱ) complex {[Cd(bpds)(bpp)2]·2H2O}n (1) with 4,4′-biphenyldisulfonic acid (H2bpds) and 1,3-bis(4-pyridyl)propane (bpp) has been synthesized by means of hydrothermal method and characterized by elemental analysis, IR spectrum, thermal analysis and single-crystal X-ray diffraction. The crystal is of triclinic, space group P1 with a=0.900 96(12) nm, b=1.098 84(14) nm, c=1.125 71(15) nm, α=115.907(2)°, β= 92.307 (2)°, γ=105.383 (2)°, V=0.950 8(2) nm3, Dc=1.497 g·cm-3, Z=1, F(000)=440, Goof=1.046, R1=0.028 2, wR2= 0.074 9. Complex 1 shows a novel two-dimensional (2D) lamellar structure and further extended into a 3D supramolecular structure through O-H…O and C-H…O hydrogen bonding interactions. Luminescent studies show that complex 1 exhibits intense blue fluorescent emission. CCDC: 769593.     

Synthesis,Bioactivity and Crystal Structure Analysis of Diisopropyl[（4-cyanopyrazol-3-ylamino）（2-hydroxyl-phenyl） methyl]phosphonate

The title compound,diisopropyl[(4-cyanopyrazol-3-ylamino)(2-hydroxylphenyl) -methyl] phosphonate was synthesized by the addition reaction of diisopropyl phosphite and N-(4-cyanopyrazole-3-yl) -2-hydroxylphenyl-imine. Its structure was characterized by IR,1H NMR,elemental analysis and single-crystal X-ray diffraction. The crystal belongs to the triclinic system,space group P1 with a = 9.1840(13) ,b = 9.2278(13),c = 12.1952(17) ,α = 93.846(2) ,β = 90.947(2) ,γ = 111.289(2) °,V = 959.9(3) 3,Dc = 1.309 g/cm3,Z = 2,μ(MoKa) = 0.173,F(000) = 400,the final R = 0.0414 and wR = 0.1196 for 2985 observed reflections(I > 2σ(I)) . The pyrazole and benzene moieties are approximately coplanar in each case. The dihedral angle between planes 1 and 2 is 82.99°. The crystal structure is stabilized by three intermolecular hydrogen bonds of O(1) -H(1) …O(2) ,N(2) -H(2) …N(3) and N(2) -H(2) …O(1) . Preliminary bioassay indicated that the title compound possessed antiviral activity to some extent.     

Structure of a Polymeric Mn(Ⅱ) Complex Bridged by Benzenetetracarboxylate

The single crystals of the title compound were obtained from a reaction of MnCO3,benzenetetracarboxylic acid (H4BTC)and imidazole in an aqueous solution.The crystal of Mn(II)complex (C28H34Mn2N12O12(4H2O,Mr=912.62) belongs to tricli nic,space group Pī with a=10.036(1),b=10.650(1),c=11.102(1)A,α=114.72(2),β=95.75(1),γ=108.46(2)°,V=984.2(2)A3,Z=1,Dc=1.540 g/cm3,F(000)=472,μ(MoKα)=0.726 mm-1,R=0.0409 and wR=0.1166 for 3909 observed reflections (I>2σ(I)).The crystal consists of the polymeric Mn(II)complex anions and discrete Mn(II) complex cations,both with normal octahedral coordination geometry.Each BTC bridges two Mn(II) atoms to form the anionic polymeric chain,and the cations distribute be-tween the chains and link them through both classic and weak C-H…O H-bonding.